{"id":15869,"date":"2020-10-26T11:32:59","date_gmt":"2020-10-26T10:32:59","guid":{"rendered":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/"},"modified":"2020-10-26T11:35:06","modified_gmt":"2020-10-26T10:35:06","slug":"certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system","status":"publish","type":"post","link":"https:\/\/www.certest.es\/es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/","title":{"rendered":"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122"},"content":{"rendered":"<p>ZARAGOZA, Espa\u00f1a y FRANKLIN LAKES, Nueva Jersey, 21 de octubre de 2020 \/ PRNewswire \/ &#8211; Certest Biotec, junto con BD (Becton, Dickinson and Company) (NYSE: BDX), empresa l\u00edder mundial en tecnolog\u00eda m\u00e9dica, anunciaron que el kit VIASURE de detecci\u00f3n de PCR en tiempo real SARS-CoV-2 (N1 + N2) adaptado para el sistema BD MAX \u2122 tiene el marcado CE* seg\u00fan la Directiva IVD (98\/79 \/ EC).<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-medium wp-image-15863\" src=\"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/imagen_noticia_Certest_BDMax_VIASURE-300x259.jpg\" alt=\"\" width=\"300\" height=\"259\" \/><\/p>\n<p>Este kit permite a los usuarios del sistema BD MAX\u2122 ejecutar un \u00fanico m\u00f3dulo que diagnostica simult\u00e1neamente COVID-19, Influenza (gripe) y el virus respiratorio sincitial (RSV).<\/p>\n<p>En palabras de Nelson Fernandes, Director General de Certest Biotec, \u00abel nuevo kit proporcionar\u00e1 capacidades de diagn\u00f3stico r\u00e1pidas frente al COVID-19 que se pueden ejecutar de forma individual o combinada con la detecci\u00f3n de la gripe A, la gripe B y RSV A y B. A medida que entramos en la temporada de gripes, la capacidad de realizar pruebas de COVID-19 y de influenza al mismo tiempo acelerar\u00e1 el diagn\u00f3stico y, en \u00faltima instancia, el tratamiento\u00bb.<\/p>\n<p>La plataforma de diagn\u00f3stico molecular BD MAX\u2122 se utiliza ampliamente en cientos de laboratorios en toda Europa. Cada unidad puede arrojar resultados en dos o tres horas, y es capaz de analizar cientos de muestras durante un per\u00edodo de 24 horas.<\/p>\n<p>\u00abJunto con Certest, podemos ofrecer a nuestros clientes en Europa una soluci\u00f3n completa para el diagn\u00f3stico de COVID-19 durante la temporada de invierno\u00bb, explica Nikos Pavlidis, vicepresidente de Diagn\u00f3stico Molecular y Salud de la Mujer de BD. \u00abAl aprovechar nuestra importante base instalada y la versatilidad del sistema BD MAX, esta prueba mejorar\u00e1 en gran medida la capacidad para las pruebas de SARS-CoV-2 e Influenza, lo que permitir\u00e1 a los m\u00e9dicos diagnosticar r\u00e1pidamente a los pacientes y ayudar a reducir la propagaci\u00f3n de COVID-19\u00bb.<\/p>\n<p>Las pruebas Certest encajan en la posici\u00f3n espec\u00edfica de la prueba en la tira de extracci\u00f3n BD MAX \u2122 ExK \u2122 TNA, suministrada por BD.<\/p>\n<p>El kit de detecci\u00f3n de PCR en tiempo real VIASURE SARS-CoV-2 (N1 + N2) para el sistema BD MAX\u2122 y el kit de detecci\u00f3n de PCR en tiempo real VIASURE Flu A, Flu B &amp; RSV para el sistema BD MAX\u2122 se venden a trav\u00e9s de la red de BD, \u00a0y no est\u00e1n disponibles para la venta en los Estados Unidos.<\/p>\n<p>Para localizar un representante autorizado de BD o solicitar informaci\u00f3n, visite:<\/p>\n<p><a href=\"http:\/\/www.bd.com\" target=\"_blank\" rel=\"noopener noreferrer\">www.bd.com<\/a><\/p>\n<p><a href=\"https:\/\/www.certest.es\" target=\"_blank\" rel=\"noopener noreferrer\">www.certest.es<\/a> *<\/p>\n<p>*BD and BD MAX trademarks are property of BD (Becton, Dickinson and Company)<\/p>\n<p>*VIASURE is a registered trademark of Certest Biotec, S.L.<\/p>\n<p>Fuente: <a href=\"https:\/\/investors.bd.com\/news-releases\/news-release-details\/certest-biotec-and-bd-announce-ce-mark-combination-covid-19\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/investors.bd.com\/news-releases\/news-release-details\/certest-biotec-and-bd-announce-ce-mark-combination-covid-19<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ZARAGOZA, Espa\u00f1a y FRANKLIN LAKES, Nueva Jersey, 21 de octubre  [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":15866,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1268,23],"tags":[972,112,113,948,140],"class_list":["post-15869","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19-es","category-destacadas","tag-bd-es","tag-biotec","tag-certest","tag-covid-19-es","tag-viasure"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122 - Certest Biotec - Raw Materials | Diagnostics | Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122 - Certest Biotec - Raw Materials | Diagnostics | Pharma\" \/>\n<meta property=\"og:description\" content=\"ZARAGOZA, Espa\u00f1a y FRANKLIN LAKES, Nueva Jersey, 21 de octubre [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Certest Biotec - Raw Materials | Diagnostics | Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-26T10:32:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-26T10:35:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Certest\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Certest\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/\",\"url\":\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/\",\"name\":\"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122 - Certest Biotec - Raw Materials | Diagnostics | Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.certest.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg\",\"datePublished\":\"2020-10-26T10:32:59+00:00\",\"dateModified\":\"2020-10-26T10:35:06+00:00\",\"author\":{\"@id\":\"https:\/\/www.certest.es\/#\/schema\/person\/38733cd75f271eac2cfe4d21d435a510\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#primaryimage\",\"url\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg\",\"contentUrl\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg\",\"width\":700,\"height\":403},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.certest.es\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.certest.es\/#website\",\"url\":\"https:\/\/www.certest.es\/\",\"name\":\"Certest Biotec - Raw Materials | Diagnostics | Pharma\",\"description\":\"Productos para diagn\u00f3stico in vitro\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.certest.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.certest.es\/#\/schema\/person\/38733cd75f271eac2cfe4d21d435a510\",\"name\":\"Certest\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122 - Certest Biotec - Raw Materials | Diagnostics | Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/","og_locale":"es_ES","og_type":"article","og_title":"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122 - Certest Biotec - Raw Materials | Diagnostics | Pharma","og_description":"ZARAGOZA, Espa\u00f1a y FRANKLIN LAKES, Nueva Jersey, 21 de octubre [...]","og_url":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/","og_site_name":"Certest Biotec - Raw Materials | Diagnostics | Pharma","article_published_time":"2020-10-26T10:32:59+00:00","article_modified_time":"2020-10-26T10:35:06+00:00","og_image":[{"width":700,"height":403,"url":"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg","type":"image\/jpeg"}],"author":"Certest","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Certest","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/","url":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/","name":"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122 - Certest Biotec - Raw Materials | Diagnostics | Pharma","isPartOf":{"@id":"https:\/\/www.certest.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#primaryimage"},"image":{"@id":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg","datePublished":"2020-10-26T10:32:59+00:00","dateModified":"2020-10-26T10:35:06+00:00","author":{"@id":"https:\/\/www.certest.es\/#\/schema\/person\/38733cd75f271eac2cfe4d21d435a510"},"breadcrumb":{"@id":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#primaryimage","url":"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg","contentUrl":"https:\/\/www.certest.es\/wp-content\/uploads\/2020\/10\/img_inicio_CerTest_BDMax_VIASURE.jpg","width":700,"height":403},{"@type":"BreadcrumbList","@id":"https:\/\/www.certest.es\/news\/certest-biotec-and-bd-announce-ce-mark-for-combination-covid-19-influenza-rsv-test-on-bd-max-molecular-diagnostic-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.certest.es\/es\/"},{"@type":"ListItem","position":2,"name":"Certest Biotec y BD anuncian la obtenci\u00f3n del marcado CE para la prueba combinada de COVID-19, Influenza y RSV en el sistema de diagn\u00f3stico molecular BD MAX\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.certest.es\/#website","url":"https:\/\/www.certest.es\/","name":"Certest Biotec - Raw Materials | Diagnostics | Pharma","description":"Productos para diagn\u00f3stico in vitro","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.certest.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.certest.es\/#\/schema\/person\/38733cd75f271eac2cfe4d21d435a510","name":"Certest"}]}},"_links":{"self":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts\/15869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/comments?post=15869"}],"version-history":[{"count":0,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts\/15869\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/media\/15866"}],"wp:attachment":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/media?parent=15869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/categories?post=15869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/tags?post=15869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}